Context Therapeutics Inc. (CNTX)
(Real Time Quote from BATS)
$2.17 USD
+0.05 (2.36%)
Updated Jul 22, 2024 11:08 AM ET
3-Hold of 5 3
D Value C Growth F Momentum D VGM
Cash flow Statements
Fiscal Year End for Context Therapeutics Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -23.96 | -14.84 | -10.46 | 6.64 | NA |
Depreciation/Amortization & Depletion | 0.01 | 0.01 | 0.00 | 0.00 | NA |
Net Change from Assets/Liabilities | 1.78 | -0.28 | -2.22 | 1.32 | NA |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Operating Activities | 1.13 | 1.55 | 3.88 | -9.00 | NA |
Net Cash From Operating Activities | -21.05 | -13.55 | -8.80 | -1.04 | NA |
Property & Equipment | 0.00 | -0.04 | 0.00 | 0.00 | NA |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Investing Activities | 0.00 | -0.50 | -0.25 | 0.00 | NA |
Net Cash from Investing Activities | 0.00 | -0.54 | -0.25 | 0.00 | NA |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | 0.00 | 58.39 | 1.00 | NA |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.15 | NA |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Financing Activities | 0.00 | -0.10 | 0.00 | 0.00 | NA |
Net Cash from Financing Activities | 0.00 | -0.10 | 58.39 | 1.15 | NA |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Net Change In Cash & Equivalents | -21.05 | -14.19 | 49.34 | 0.11 | NA |
Cash at Beginning of Period | 35.50 | 49.69 | 0.34 | 0.23 | NA |
Cash at End of Period | 14.45 | 35.50 | 49.69 | 0.34 | NA |
Diluted Net EPS | -1.50 | -0.93 | -3.69 | NA | NA |
Fiscal Year End for Context Therapeutics Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -3.67 | -23.96 | -17.19 | -11.32 |
Depreciation/Amortization & Depletion | NA | 0.00 | 0.01 | 0.01 | 0.01 |
Net Change from Assets/Liabilities | NA | -0.94 | 1.78 | 2.49 | 0.34 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 0.24 | 1.13 | 0.87 | 0.61 |
Net Cash From Operating Activities | NA | -4.36 | -21.05 | -13.82 | -10.36 |
Property & Equipment | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | -4.36 | -21.05 | -13.82 | -10.36 |
Cash at Beginning of Period | NA | 14.45 | 35.50 | 35.50 | 35.50 |
Cash at End of Period | NA | 10.09 | 14.45 | 21.68 | 25.14 |
Diluted Net EPS | NA | -0.23 | -0.42 | -0.37 | -0.31 |